BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Global Biodefense - ECPv6.18.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://globalbiodefense.com
X-WR-CALDESC:Events for Global Biodefense
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20170312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20171105T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20180311T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20181104T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20190310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20191103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20180311T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20181104T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20170312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20171105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20180311T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20181104T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190220
DTEND;VALUE=DATE:20190221
DTSTAMP:20190429T044315Z
CREATED:20190121T182518Z
LAST-MODIFIED:20190429T044315Z
UID:20647-1550620800-1550707199@globalbiodefense.com
SUMMARY:Mass Drug Administration and Antimicrobial Resistance
DESCRIPTION:The London School of Hygiene & Tropical Medicine Antimicrobial Resistance Center\, together with the MARCH and Malaria Centres will jointly host the Mass Drug Administration and Antimicrobial Resistance Symposium on 20 February 2019 in London\, UK and by live stream. \nMass Drug Administration is an intervention proposed to reduce morbidity and mortality of entire populations. This symposium will bring together academics from a range of relevant disciplines to discuss the state of evidence\, and draw out a future integrated research agenda that addresses potential hurdles with this approach\, including concerns about antimicrobial resistance. \nPlease visit the LSHTM Antimicrobial Resistance Centre’s website for more information.
URL:https://globalbiodefense.com/event/mass-drug-administration-antimicrobial-resistance/
LOCATION:John Snow Lecture Theatre – LSHTM\, Keppel Street\, London\, WC1E 7HT\, United Kingdom
CATEGORIES:Conference,Webinar-Webcast
ATTACH;FMTTYPE=image/png:https://globalbiodefense.com/wp-content/uploads/2019/01/mass-drug-administration-amr-lshtm.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190205T103000
DTEND;TZID=America/New_York:20190205T153000
DTSTAMP:20190125T022341Z
CREATED:20190115T023245Z
LAST-MODIFIED:20190125T022341Z
UID:20475-1549362600-1549380600@globalbiodefense.com
SUMMARY:Fighting the Next War: Defense Against Biological Weapons
DESCRIPTION:The Blue Ribbon Study Panel on Biodefense will host an in-depth discussion on the role of the U.S. Defense Department in biodefense on February 5th\, 2019 in Washington\, DC. \nParticipants will share their experiences regarding the current threat environment\, research and development programs\, and the Department’s biodefense policies. \nRSVP by January 30\, 2019. Attendance is free\, but registration is required. This event will also be webcast.
URL:https://globalbiodefense.com/event/fighting-the-next-war-defense-against-biological-weapons/
LOCATION:Council on Foreign Relations\, 1777 F Street\, NW\, Washington\, DC\, 20006\, United States
CATEGORIES:Webinar-Webcast,Workshop
ATTACH;FMTTYPE=image/png:https://globalbiodefense.com/wp-content/uploads/2019/01/blue-ribbon-study-panel-biodefense.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190204
DTEND;VALUE=DATE:20190205
DTSTAMP:20190121T195504Z
CREATED:20190121T195112Z
LAST-MODIFIED:20190121T195504Z
UID:21908-1549238400-1549324799@globalbiodefense.com
SUMMARY:National Toxicology Program Peer-Review Meeting on Effects of Sarin Exposure
DESCRIPTION:The National Toxicology Program will host a public webinar on 4 Feb 2019 to discuss the draft findings of a systematic review to evaluate the evidence for long-term neurological effects in humans and animals following acute exposure to sarin. \nSarin is a highly toxic organophosphorus nerve agent that was developed for chemical warfare during World War II and continues to be used as a weapon. Long-term neurological effects of acute exposure to sarin are not well characterized. \nRegistration is required for attendance and to present oral comments. The webcast is open to the public. \nLearn more: Long-Term Effects Following Acute Exposure to Sarin Nerve Agent
URL:https://globalbiodefense.com/event/peer-review-meeting-on-long-term-effects-of-nerve-agent-exposure/
LOCATION:Webinar
CATEGORIES:Webinar-Webcast,Workshop
ATTACH;FMTTYPE=image/png:https://globalbiodefense.com/wp-content/uploads/2019/01/sarin-nerve-agent.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190129T123000
DTEND;TZID=America/New_York:20190129T140000
DTSTAMP:20190125T045928Z
CREATED:20190125T045201Z
LAST-MODIFIED:20190125T045928Z
UID:22193-1548765000-1548770400@globalbiodefense.com
SUMMARY:Fighting Ebola in DRC: New Tools and New Challenges
DESCRIPTION:Join Doctors Without Borders for a live webcast panel discussion on January 29 from 12:30 PM – 2:00 PM EST on efforts to contain the current Ebola epidemic in Democratic Republic of Congo (DRC). \nMSF teams are responding to the second largest Ebola outbreak ever recorded\, trying to halt the spread of this highly infectious\, deadly disease. The epicenter of the outbreak is in a conflict area in North Kivu province\, making a rapid response difficult. \nPanelists will explore the evolving medical approaches to fighting the Ebola virus\, the initiation of a randomized controlled trial testing treatment options\, and the unique ethical and logistical considerations this outbreak presents. \nAt the time of the event\, tune in to the webcast here. \n\nKarin Huster\, MSF Project Coordinator\, earned a BS in Nursing from the University of Washington in 2005 and her Master in Public Health degree from UW’s department of global health in 2013. After nine years working as a nurse in the intensive care unit of a large trauma center\, Karin now focuses on responding to humanitarian emergencies\, either in a clinical capacity\, as a field epidemiologist\, or field coordinator. She has also worked as an advisor to the emergency response branch of USAID. Most recently\, Karin returned from DRC where she helped launch MSF’s response to the Ebola outbreak and later returned to manage an MSF transit center for people with suspected cases of Ebola. In 2014\, she worked as part of the response in each of the three West African countries affected by the largest Ebola outbreak in history. She has also worked in Iraq\, Bangladesh\, Nigeria\, Haiti\, and Lebanon. \nDr. Brian D’Cruz\, MSF Physician\, has worked with MSF since 2011\, and recently returned from MSF’s Ebola intervention in Beni\, DRC. In 2014–2015\, Brian participated in MSF’s response to the West Africa Ebola outbreak in Guinea. He has also worked at MSF projects in Burundi\, Central African Republic\, Syria\, and Chad. \nDr. Tomas Jensen\, MSF Tropical Medicine Advisor\, is an infectious diseases physician currently based in New York as an advisor on tropical medicine and epidemics for MSF. He started working with MSF in 2006 as a field doctor and has worked in several countries including South Sudan\, Ethiopia\, Zimbabwe\, South Africa\, and Zambia. After finishing medical school in Denmark\, Tomas completed infectious diseases specialist training in Australia and a master’s degree in epidemiology with the London School of Hygiene and Tropical Medicine. \nThe discussion will be moderated by Sandra Murillo\, MSF-USA Media Relations Director.
URL:https://globalbiodefense.com/event/msf-fighting-ebola-in-drc-new-tools-new-challenges/
LOCATION:Webinar
CATEGORIES:Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2019/01/ebola-msf-doctors-without-borders.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181203
DTEND;VALUE=DATE:20181204
DTSTAMP:20181224T222714Z
CREATED:20181115T024057Z
LAST-MODIFIED:20181224T222714Z
UID:18849-1543795200-1543881599@globalbiodefense.com
SUMMARY:FDA Public Webinar: Genome Editing in Animals
DESCRIPTION:On December 3\, 2018\, the U.S. Food and Drug Administration’s Center for Veterinary Medicine (CVM)\, with participation from the FDA’s Center for Biologics Evaluation and Research (CBER)\, will hold a public webinar about genome editing in animals. \nGenome editing is an innovative and rapidly evolving technology that offers many promising benefits to both human and animal health\, animal well-being\, and food production. This webinar is an initial step in FDA’s public communication strategy to help innovators understand FDA regulation and show support for safe and responsible innovation that benefits public health. \nThe webinar will focus primarily on the current scientific evidence\, promising uses of this technology in animals\, and the potential risks. It will also provide information about CVM’s flexible\, risk-based approach to the regulation of intentional genomic alterations to animals and address common misconceptions associated with the regulation of these products. A portion of the webinar will be dedicated to answering stakeholder-submitted questions. \nGenome editing in plants for human and/or animal food will not be covered. \nThe webinar is open to the public\, but advance registration is required to participate in the live-cast webinar. \nSee also: \n\nRegistration: CVM Public Webinar about Genome Editing in Animals\nFDA’s Regulation of Plant and Animal Biotechnology Products\nFDA Plant and Animal Biotechnology Innovation Action Plan\nCVM Update: FDA Announces Plant and Animal Biotechnology Innovation Action Plan\nStatement from FDA Commissioner Scott Gottlieb\, M.D.\, and Deputy Commissioner Anna Abram on the FDA’s new plan to advance plant\, animal biotechnology innovation
URL:https://globalbiodefense.com/event/fda-public-webinar-genome-editing-in-animals/
LOCATION:Online
CATEGORIES:Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2017/02/dna-genomics.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20181126T140000
DTEND;TZID=America/New_York:20181126T190000
DTSTAMP:20181226T181110Z
CREATED:20181226T180747Z
LAST-MODIFIED:20181226T181110Z
UID:18701-1543240800-1543258800@globalbiodefense.com
SUMMARY:A Century After the 1918 Flu Pandemic: Why Are We Still Concerned Today?
DESCRIPTION:Please join us on Monday\, November 26\, 2018\, in Washington\, DC\, for a momentous occasion reflecting on the 100th anniversary of the influenza pandemic of 1918. A panel discussion entitled “A Century After the 1918 Influenza Pandemic—Why Are We Still Concerned Today?” cohosted by the National Academy of Medicine\, with the Forum on Microbial Threats\, will be held from 2:00 – 5:00 PM\, with an exhibit highlighting infectious disease outbreaks and a cocktail reception to follow. \nOur distinguished panelists will establish why pandemic influenza continues to be a major societal concern\, as well as highlight the global progress and benefits of driving science\, public health\, global governance\, and cross-sectoral alliances for pandemic influenza preparedness. An agenda for the event can be found here. A free live webcast will be available. Use this page to register for the webcast as well as the in-person event.   \nThe discussions will allow the following 1.5-day workshop\, hosted by the Forum on Microbial Threats\, to focus on the identified priority areas of concern for pandemic influenza and other emerging infectious diseases. For more information on the November 27-28 workshop on “Readiness for Microbial Threats 2030: Exploring Lessons Learned Since the 1918 Influenza Pandemic\,” please visit the event page. Public registration for the workshop is now open!
URL:https://globalbiodefense.com/event/a-century-after-the-1918-flu-pandemic-why-are-we-still-concerned-today/
LOCATION:National Academy of Sciences\, 2101 Constitution Avenue Northwest\, Washington\, DC\, 20418\, United States
CATEGORIES:Webinar-Webcast,Workshop
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2018/12/1918-influenza-pandemic.jpg
END:VEVENT
END:VCALENDAR